Class II · Moderate risk
Dupixent 300 mg/2 mL PFS #2 w/ NS NDC 00024-5914-01 28 days supply
Lack of Processing Controls.
FDA drug recalls in 2018
Every FDA drug recall initiated in 2018, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
1,681 recalls, newest first.
Class II · Moderate risk
Vosevi 400/100/100 mg Tablets #28 NDC 61958-2401-01 28 days supply.
Lack of Processing Controls.
Class II · Moderate risk
Xolair 150 mg SDV NDC 50242-0040-62 28 days
Lack of Processing Controls.
Class II · Moderate risk
Sodium Chloride 3% Inh. 4 mL NEP #30 NDC 00487-9003-60 30 days supply.
Lack of Processing Controls.
Class II · Moderate risk
MVW Complete Softgels NDC 58204-0004-00 30 days supply
Lack of Processing Controls.
Class II · Moderate risk
Creon DR 24
Lack of Processing Controls.
Class II · Moderate risk
Azithromycin 250 mg tablet #18 TEV NDC 50111-0787-66 28 days supply
Lack of Processing Controls.
Class II · Moderate risk
Pulmozyme 1 mg/mL Inh. Soln. #30 NDC 50242-0100-40 30 days supply.
Lack of Processing Controls.
Class II · Moderate risk
Bethkis 300 mg/4 mL Ampule #56 NDC 10122-0820-56 56 days supply
Lack of Processing Controls.
Class II · Moderate risk
Orkambi 100 mg/125 mg Tablets #112 NDC 51167-0700-02 28 days supply.
Lack of Processing Controls.
Class II · Moderate risk
Orkambi 200 mg/125 mg Tablets #112 NDC 51167-0809-01 28 days supply.
Lack of Processing Controls.
Class II · Moderate risk
Kitabis Pak 300 mg/5 mL Soln PARI #56 NDC 24492-0850-56 56 days supply
Lack of Processing Controls.
Class II · Moderate risk
Prolia 60 mg/1 mL PF syringe NDC 55513-0710-01 180 days supply.
Lack of Processing Controls.
Class II · Moderate risk
Botox 100 Units Vial NDC 00023-1145-01 90 days supply.
Lack of Processing Controls.
Class II · Moderate risk
Enbrel PFS 50 mg/mL Inj #4 NDC 58406-0435-04 28 days supply
Lack of Processing Controls.
Class II · Moderate risk
Repatha 140 mg/mL Sureclick AI 2-pk NDC 55513-0760-02 28 days supply
Lack of Processing Controls.
Class II · Moderate risk
Cayston 75 mg Inh. Soln. SDV NDC 61958-0901-01 56 days supply
Lack of Processing Controls.
Class II · Moderate risk
Altera Handset NDC 83490-0678-05 56 days supply
Lack of Processing Controls.
Class II · Moderate risk
Cosentyx 150 mg/mL PFS 300 mg Dose NDC 00078-0639-98
Lack of Processing Controls.
Class II · Moderate risk
Taltz 80 mg/mL Pen 1-pk NDC 00002-1445-11 28 days supply
Lack of Processing Controls.
Class II · Moderate risk
Otezla 30 mg tablet NDC 59572-0631-06 30 days supply
Lack of Processing Controls.
Class II · Moderate risk
Pulmicort Respules 0.5 mg/2mL s
Lack of Processing Controls.
Class II · Moderate risk
Polyethylene Glycol 3350
Lack of Processing Controls.
Class II · Moderate risk
Pediasure Liq. Vanilla G+G
Lack of Processing Controls.
Class II · Moderate risk
Kalydeco 150 mg tablet blister
Lack of Processing Controls.